Premises Requirements for Medical Device Business Activities in Macao

Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

Premises used for medical device business activities in Macao, China (manufacturing, distribution, wholesale, retail and the like) must meet the statutory requirements on layout, facilities and equipment. The relevant technical requirements are set out in Dispatch No. 36/2026 of the Secretary for Social Affairs and Culture and are implemented through the licence application and inspection provisions of Administrative Regulation No. 11/2026. Premises requirements are substantive conditions of licence approval, not formalities — the ISAF verifies them on site at the inspection stage, and premises that fail to meet the requirements lead directly to refusal of the licence. Companies should engage in compliance design at the leasing and fit-out stages; retrofitting afterwards costs far more than planning ahead.

  • Premises conditions are verified on site and directly determine whether the licence is issued.
  • Layout requirements are set by Dispatch No. 36/2026 of the Secretary for Social Affairs and Culture.
  • The core logic of the layout rules is to prevent contamination, mix-ups and errors through separated functional zones.
  • Facility and equipment standards are tiered by business type, with manufacturing the most demanding.
  • The transitional period for existing premises allows late licensing but not lower standards.

2. Legal basis

The framework combines the technical dispatch on premises, the procedural provisions of the implementing rules, and the licence provisions of the parent law. The table below lists the instruments and provisions cited in this article.

Regulatory instrumentReferencePublication dateProvisions
Dispatch laying down the requirements for the layout, facilities and equipment of premises for medical device business activitiesDispatch No. 36/2026 of the Secretary for Social Affairs and CulturePublished in 2026; effective on 1 July 2026Full text of the dispatch (layout, facilities and equipment requirements for premises)
Implementing Rules of the Medical Devices Regulatory RegimeAdministrative Regulation No. 11/2026 (Official Gazette No. 20/2026)Published on 18 May 2026; effective on 1 July 2026Application provisions for the manufacturing licence and the business licence; article on applying for inspection (inspection within 15 working days, one-year time limit); article on the inspection record (20 working days); article on approval of plans and notification
Medical Devices Regulatory RegimeLaw No. 12/2025 (Official Gazette No. 30/2025)Published on 28 July 2025; effective on 1 July 2026Article 31 (categories of licences); Article 32 (manufacturing licence); Article 33 (requirements for issue or renewal); Article 35 (business rules for manufacturing plants); Article 66 (transitional arrangements for existing premises)

3. Expert insights

Insight one: premises requirements are inspection-triggered conditions. The implementing rules split the licence procedure into a document review stage and an on-site inspection stage, with the inspection completed by the ISAF within the statutory period and an inspection record drawn up. This means that premises compliance is not self-evidenced through the application documents but verified on site. The most frequent failure mode GRZAN encounters when coaching clients from the Chinese mainland is a file prepared in exhaustive detail, followed by a demand for rectification at the site inspection because the layout or facilities fail to meet the standard — wasting an entire additional cycle.

Insight two: the core of the layout requirement is that functional zones do not cross. Dispatch No. 36/2026 of the Secretary for Social Affairs and Culture specifies the layout that premises must have according to the nature of the business activity. The underlying logic is to prevent contamination, mix-ups and errors — storage, display, office and non-conforming (or pending) goods areas should be effectively separated. Practical estimate: the specific areas, wall forms and number of zones are governed by the official text of the dispatch and the on-site views of the ISAF; do not copy experience values from the Chinese mainland or other markets.

Insight three: facilities and equipment are tiered by business type. Manufacturing activities and distribution activities (wholesale, retail) face requirements of a different order. Manufacturing must cover the full chain of production, testing and storage, while the distribution stage focuses more on storage conditions, temperature and humidity control and display conditions. Before planning their premises, companies must first confirm which category of licence they are applying for — the licence category determines the premises standard, not the other way round.

Insight four: the transitional period gives existing premises a buffer, but no exemption. Article 66 of Law No. 12/2025 provides transitional arrangements for existing premises. The significance of the transitional period is that operations may continue while licensing is completed, not that premises standards may be lowered. When licensing is completed, the requirements of Dispatch No. 36/2026 of the Secretary for Social Affairs and Culture must still be met. Practical estimate: existing premises are advised to complete self-assessment and rectification early in the transitional period, to avoid a rush of clustered applications shortly before the deadline.

Insight five: changes to the premises can affect the licence itself. The premises are one of the particulars recorded in the licence; relocation, expansion or changes to the functional zoning may all constitute a change to the licence particulars, must be handled under the change procedure, and may trigger a re-inspection. A window for handling compliance changes should be reserved in lease negotiations; otherwise a single relocation interrupts the continuity of the licence.

4. Practical recommendations

  • Fix the licence category first, then the premises plan: manufacturing and distribution standards differ substantially; the order cannot be reversed.
  • Complete a compliance pre-review before fit-out: push the layout and facility requirements upstream into the design drawings stage.
  • Reserve a window for rectification: post-inspection rectification consumes extra time; do not schedule on the assumption of passing at the first attempt.
  • Start the transitional-period self-assessment for existing premises early: do not wait until just before the deadline.
  • Confirm the change procedure before relocating: avoid interruption of the licence affecting business continuity.

5. Verification checklist

  • □ Licence category to be applied for and the corresponding premises standard confirmed
  • □ Official text of Dispatch No. 36/2026 of the Secretary for Social Affairs and Culture obtained
  • □ Layout plan (functional zoning) meeting the requirements of the dispatch
  • □ Facility and equipment list completed according to the business type
  • □ Inspection stage (15 working days inspection, 20 working days record) built into the schedule
  • □ Rectification window reserved in the project plan
  • □ Transitional-period time limit for existing premises (Article 66) confirmed
  • □ Licence change path for premises changes clarified

Regulatory information verified as of 29 October 2026. The laws, guidelines and effective dates described in this article are limited to the content published by the official sources listed under Legal basis as of that date; where official documents are updated, the most recently published version prevails.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for Macao, China. Our team coordinates local licence holder arrangements, import and supply requirements, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail